{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:17:48Z","timestamp":1783577868976,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005612","name":"Shionogi and Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K19450"],"award-info":[{"award-number":["JP19K19450"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K17408"],"award-info":[{"award-number":["JP22K17408"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jiac.2026.102905","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T16:11:38Z","timestamp":1767715898000},"page":"102905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["In vitro activity of cefiderocol against carbapenem-resistant Gram-negative pathogens in Japan"],"prefix":"10.1016","volume":"32","author":[{"given":"Kenjiro","family":"Matsui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2198-8954","authenticated-orcid":false,"given":"Aki","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Hosoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Hase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7853-5721","authenticated-orcid":false,"given":"Hideaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9957-0510","authenticated-orcid":false,"given":"Takashi","family":"Matono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6269-7884","authenticated-orcid":false,"given":"Naoya","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8953-5962","authenticated-orcid":false,"given":"Momoko","family":"Mawatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9620-2525","authenticated-orcid":false,"given":"Yohei","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2026.102905_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cmi.2023.11.008","article-title":"Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)","volume":"30","author":"Paniagua-Garc\u00eda","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2026.102905_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jgar.2022.04.004","article-title":"Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in Japan","volume":"29","author":"Oka","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jiac.2026.102905_bib3","doi-asserted-by":"crossref","first-page":"dlaf027","DOI":"10.1093\/jacamr\/dlaf027","article-title":"Molecular epidemiology and patient outcome of carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii in Japan: a multicenter study from MultiDrug-Resistant organisms clinical research network","volume":"7","author":"Saito","year":"2025","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.jiac.2026.102905_bib4","doi-asserted-by":"crossref","first-page":"dlad152","DOI":"10.1093\/jacamr\/dlad152","article-title":"Activity of ceftolozane\/tazobactam, imipenem\/relebactam and ceftazidime\/avibactam against clinical Gram-negative isolates\u2014Smart United States 2019\u201321","volume":"6","author":"Karlowsky","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.jiac.2026.102905_bib5","doi-asserted-by":"crossref","first-page":"dlad070","DOI":"10.1093\/jacamr\/dlad070","article-title":"Evolving landscape of carbapenem-resistant Pseudomonas aeruginosa at a single centre in the USA","volume":"5","author":"Sakurai","year":"2023","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.jiac.2026.102905_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00642-17","article-title":"Identifying Spectra of activity and therapeutic niches for ceftazidime-avibactam and Imipenem-Relebactam against carbapenem-resistant Enterobacteriaceae","volume":"61","author":"Haidar","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.102905_bib7","doi-asserted-by":"crossref","first-page":"S565","DOI":"10.1093\/cid\/ciz830","article-title":"Treatment options for carbapenem-resistant gram-negative bacterial infections","volume":"69","author":"Doi","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.102905_bib8","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1128\/AAC.01405-16","article-title":"Siderophore cephalosporin cefiderocol utilizes ferric iron transporter systems for antibacterial activity against Pseudomonas aeruginosa","volume":"60","author":"Ito","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.102905_bib9","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1093\/jac\/dkad200","article-title":"In vitro activity of cefiderocol against MBL-producing Gram-negative bacteria collected in North America and Europe in five consecutive annual multinational SIDERO-WT surveillance studies (2014\u20132019)","volume":"78","author":"Takemura","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2026.102905_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01436-20","article-title":"In vitro activity and in vivo efficacy of cefiderocol against Stenotrophomonas maltophilia","volume":"65","author":"Nakamura","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.102905_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jgar.2024.05.009","article-title":"In vitro activity of cefiderocol against carbapenemase-producing and meropenem-non-susceptible Gram-negative bacteria collected in the Japan Antimicrobial Resistant Bacterial Surveillance","volume":"38","author":"Kayama","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jiac.2026.102905_bib12","first-page":"dkae168","article-title":"Clinical characteristics and genome epidemiology of Stenotrophomonas maltophilia in Japan","author":"Hase","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2026.102905_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91456-0","article-title":"AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence","volume":"11","author":"Feldgarden","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2026.102905_bib14","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2024"},{"key":"10.1016\/j.jiac.2026.102905_bib15","doi-asserted-by":"crossref","first-page":"14132","DOI":"10.3390\/cimb46120846","article-title":"Updates on the activity, efficacy and emerging mechanisms of resistance to cefiderocol","volume":"46","author":"Bianco","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.jiac.2026.102905_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106563","article-title":"High prevalence of cefiderocol resistance in carbapenem-resistant Escherichia coli: a warning from multicenter clinical data in China","volume":"91","author":"Lu","year":"2025","journal-title":"J Infect"},{"key":"10.1016\/j.jiac.2026.102905_bib17","doi-asserted-by":"crossref","unstructured":"Moon SH, Huang E. Cefiderocol resistance in Klebsiella pneumoniae is linked to SHV extended-spectrum \u03b2-Lactamase activities and functional loss of the outer membrane porin OmpK35. Microbiol Spectr n.d.;11:e03496-22. https:\/\/doi.org\/10.1128\/spectrum.03496-22.","DOI":"10.1128\/spectrum.03496-22"},{"key":"10.1016\/j.jiac.2026.102905_bib18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/antibiotics14070703","article-title":"Mechanisms of cefiderocol resistance in carbapenemase-producing enterobacterales: insights from comparative genomics","volume":"14","author":"Tristancho-Bar\u00f3","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jiac.2026.102905_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jgar.2023.06.003","article-title":"Rapid development of cefiderocol resistance in a carbapenem-resistant Pseudomonas aeruginosa isolate associated with mutations in the pyoverdine biosynthesis pathway","volume":"34","author":"Brakert","year":"2023","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jiac.2026.102905_bib20","doi-asserted-by":"crossref","first-page":"e4472","DOI":"10.1093\/cid\/ciaa1909","article-title":"Evolution of Cefiderocol non-susceptibility in Pseudomonas aeruginosa in a patient without previous exposure to the antibiotic","volume":"73","author":"Streling","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.102905_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12866-025-03792-0","article-title":"Contribution of fepAsm, fciABC, sbaA, sbaBCDEF, and feoB to ferri-stenobactin acquisition in Stenotrophomonas maltophilia KJ","volume":"25","author":"Yeh","year":"2025","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jiac.2026.102905_bib22","doi-asserted-by":"crossref","unstructured":"Matsuo A, Matsumura Y, Mori K, Noguchi T, Yamamoto M, Nagao M. Molecular epidemiology and \u03b2-lactam resistance mechanisms of Enterobacter cloacae complex isolates obtained from bloodstream infections, Kyoto, Japan. Microbiol Spectr n.d.;13:e02485-24. https:\/\/doi.org\/10.1128\/spectrum.02485-24.","DOI":"10.1128\/spectrum.02485-24"},{"key":"10.1016\/j.jiac.2026.102905_bib23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jiph.2022.12.015","article-title":"High-risk international clones ST66, ST171 and ST78 of Enterobacter cloacae complex causing blood stream infections in Spain and carrying blaOXA-48 with or without mcr-9","volume":"16","author":"Lumbreras-Iglesias","year":"2023","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jiac.2026.102905_bib24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.cmi.2017.01.020","article-title":"ST405 NDM-5 producing Escherichia coli in Northern Italy: the first two clinical cases","volume":"23","author":"Bitar","year":"2017","journal-title":"Clin Microbiol Infection"},{"key":"10.1016\/j.jiac.2026.102905_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00243-19","article-title":"Genomic and functional analysis of emerging virulent and multidrug-resistant Escherichia coli lineage sequence type 648","volume":"63","author":"Schaufler","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.102905_bib26","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.tim.2014.09.003","article-title":"Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding","volume":"22","author":"Chen","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jiac.2026.102905_bib27","doi-asserted-by":"crossref","first-page":"ofad276","DOI":"10.1093\/ofid\/ofad276","article-title":"An NDM-Producing Escherichia coli clinical isolate exhibiting resistance to cefiderocol and the combination of ceftazidime-avibactam and aztreonam: another step toward Pan-\u03b2-Lactam resistance","volume":"10","author":"Simner","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2026.102905_bib28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jac\/dkae393","article-title":"Global emergence of Escherichia coli with PBP3 insertions","volume":"80","author":"Long","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2026.102905_bib29","article-title":"Occurrence of high levels of cefiderocol resistance in carbapenem-resistant Escherichia coli before its approval in China: a report from China CRE-Network","volume":"10","author":"Wang","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jiac.2026.102905_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01659-20","article-title":"Genetic features leading to reduced susceptibility to Aztreonam-Avibactam among Metallo-\u03b2-Lactamase-Producing Escherichia coli isolates","volume":"64","author":"Sadek","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.102905_bib31","doi-asserted-by":"crossref","DOI":"10.3201\/eid2909.230390","article-title":"Population analysis of Escherichia coli sequence type 361 and reduced cefiderocol susceptibility, France","volume":"29","author":"Jousset","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2026.102905_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01454-17","article-title":"In Vitro antibacterial properties of Cefiderocol, a novel Siderophore cephalosporin, against gram-negative bacteria","volume":"62","author":"Ito","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.102905_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgar.2025.07.004","article-title":"Cefiderocol susceptibility of Stenotrophomonas maltophilia species complex and carbapenem-resistant Pseudomonas aeruginosa isolates from blood cultures at a university hospital in Tokyo, Japan","author":"Aoki","year":"2025","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jiac.2026.102905_bib34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1089\/mdr.2022.0279","article-title":"In vitro activity of cefiderocol against Meropenem-Nonsusceptible gram-negative Bacilli with defined \u03b2-Lactamase carriage: SIDERO-WT surveillance studies, 2014-2019","volume":"29","author":"Wise","year":"2023","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jiac.2026.102905_bib35","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S1473-3099(24)00648-0","article-title":"Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study","volume":"25","author":"Shields","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2026.102905_bib36","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1093\/jac\/dkae313","article-title":"Comparative evaluation of early treatment with ceftolozane\/tazobactam versus ceftazidime\/avibactam for non-COVID-19 patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa","volume":"79","author":"Lodise","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2026.102905_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01990-21","article-title":"In vitro susceptibility of gram-negative pathogens to cefiderocol in five consecutive annual multinational SIDERO-WT surveillance studies, 2014 to 2019","volume":"66","author":"Karlowsky","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.102905_bib38","doi-asserted-by":"crossref","unstructured":"Tamma PD. Infectious diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections n.d.","DOI":"10.1093\/cid\/ciae403"},{"key":"10.1016\/j.jiac.2026.102905_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00951-20","article-title":"Cefiderocol antimicrobial susceptibility testing considerations: the achilles' heel of the Trojan horse?","volume":"59","author":"Simner","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2026.102905_bib40","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.cmi.2024.12.037","article-title":"Cefiderocol susceptibility testing: the challenge of disc diffusion","volume":"31","author":"Jeannot","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2026.102905_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01648-24","article-title":"Impact of media brand on cefiderocol disk diffusion results","volume":"63","author":"DeMarco","year":"2025","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2026.102905_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01600-22","article-title":"Potential of inaccurate cefiderocol susceptibility results: a CLSI AST subcommittee advisory","volume":"61","author":"Simner","year":"2023","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2026.102905_bib43","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3390\/antibiotics12071212","article-title":"Comparison of disk diffusion, E-Test, and broth microdilution methods for testing In vitro activity of cefiderocol in Acinetobacter baumannii","volume":"12","author":"Kolesnik-Goldmann","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jiac.2026.102905_bib44","doi-asserted-by":"crossref","first-page":"1156.e1","DOI":"10.1016\/j.cmi.2022.04.013","article-title":"Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales","volume":"28","author":"Bonnin","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2026.102905_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01649-20","article-title":"Cefiderocol antimicrobial susceptibility testing against multidrug-resistant gram-negative bacilli: a comparison of disk diffusion to broth microdilution","volume":"59","author":"Morris","year":"2020","journal-title":"J Clin Microbiol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:56:01Z","timestamp":1778594161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1341321X26000036"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102905","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity of cefiderocol against carbapenem-resistant Gram-negative pathogens in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102905"}}